American Imaging Management discusses about diagnostic imaging in a journal

American Imaging Management(R) (AIM), an operating subsidiary of WellPoint, Inc. (NYSE: WLP) and one of the leading companies in the radiology benefit management industry, today commended articles on diagnostic imaging that appear in the August 27, 2009 issue of the New England Journal of Medicine.

The article "Exposure to Low-Dose Ionizing Radiation from Medical Procedures" reviews the results of a three-year study and concludes that as many as 4 million Americans a year may receive exposure to ionizing radiation from diagnostic imaging procedures. A related editorial titled "Elements of Danger--The Case of Medical Imaging" discusses the need for physicians to assess vigilantly the trade-off between the value and potential dangers of diagnostic imaging.

"These articles reinforce the notion that while diagnostic imaging is a powerful and invaluable clinical tool, managing the use of these services based on accepted clinical guidelines offers significant benefit to patients," said David Soffa, MD, MPA, FACR, AIM's senior vice president of Medical Affairs. "These articles also highlight the need to develop better ways to share information on the radiation issues that exist with these procedures."

AIM is one of the first companies to have developed a multi-faceted patient safety program to educate patients and providers regarding radiation exposure related to diagnostic imaging. Launched in 2008, AIM's Patient Safety website (www.americanimaging.net/safety) offers users an easy-to-use tool to evaluate radiation exposure from commonly ordered diagnostic imaging procedures as well as links to other websites discussing this issue. Additionally, AIM also informs physicians when they attempt to order diagnostic imaging studies for patients who have already been exposed to high levels of radiation from previous imaging studies.

"AIM's Patient Safety program offers patients and physicians with the resources needed to make informed decisions," said Dr. Soffa. "We hope that the information contained in the NEJM encourages them to take advantage of those resources."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Scientists reveal how miRNAs shape cancer and offer new paths for treatment